Open Access Open Access  Restricted Access Subscription or Fee Access

Bacteriocin production and its application in Food and Pharmaceuticals

M.M. Nalwade, T.N. Gaikwad, R.S. Shinde, S.R. Nezkar, S.P. Owal

Abstract


Bacteriocins are ribosomal - synthesized antimicrobial peptides that inhibit the growing of pathogenic or deteriorating bacteria. Bacteriocin are a heterogenous group of bioactive bacterial peptides or proteins having variable biochemical properties. Bacteriocin is introduced to denote toxic proteins or peptide produced by any type of bacteria that is active on related bacteria but does not harm the producing cell. They are antimicrobial  peptides which are ribosomally synthesized and produced by Lactic Acid Bacteria (LAB). Now a days , there are various hazardous effect of chemicals .Instead of chemicals , bacteriocins are mostly effective in food technology which aims to extend food preservation time ,treat pathogen diseases ,cancer  therapy & maintain human health.In food processing , lactic acid bacteria (LAB) shows numerous anti-microbial activities.This is mainly due to production of organic acid , but also of other compound,such as bacteriocin and various peptides .Bacteriocins are used as a potential drug for replacing antibiotics in order to treat multiple drug resistance pathogens .The important mechanism of bacteriocins is pore formation.Bacteriocins are used  as food preservation against contaminating organism .It also used against anti-tumor drug in pharmaceutical .They play major role in prevention of human diseases such as cancer ,inflammatory  diseases ,respiratory infection ,intestinal disorders ,etc.The species of Bacillus ,Staphylococcus ,Escherichia, Klebsiella ,Lactobacillus ,Pseudomonas ,Proteus  are successfully used .These are isolated from vegetables, dairy ,cheese , meat and other products. Therefore ,Bacteriocin may become a potential drug candidates for replacing antibiotics in order to treat multiple drugs resistance pathogens in the future .Bacteriocin become one of the weapons against micro-organisms due to the specific characteristics of large diversity of structure and function ,natural resource and being stable to heat.

Keywords


Bacteriocin, Lactic acid bacteria, Cancer therapy, Pore formation, Antimicrobial activity

Full Text:

PDF

References


Riley, M. A., and Wertz, J. E. Bacteriocins: evolution, ecology, and application. Annu. Rev. Microbiol. 2002:56:117–137. doi:10.1146/annurev.micro.56.012302.161024.

Deegan, L. H., Cotter, P. D., Hill, C., and Ross, P. Bacteriocins: biological tools for bio-preservation and shelf-life extension. Int. Dairy J. 2006:16:1058–1071. doi: 10.1016/j.idairyj.2005.10.026 .

Settanni, L., and Corsetti, A. Application of bacteriocins in vegetable food biopreservation. Int. J. Food Microbiol. 2008:121(2):123-138. doi:10.1016/j.ijfoodmicro.2007.09.001 .

Vijai Pal, MarilinggappaJamuna and KadirveluJeevaratnam. Isolation and Characterization of Bacteriocin producing lactic acid bacteria from South Indian special dosa (appam) Batter. Journal of culture collections. 2004:4: 53-60.

Burianek, L.L., and Yousef, A.E. Solvent Extraction of Bacteriocins from liquid cultures. Letters in Applied Microbiology. 2000:31(3):193-197.

Ohmomo, S., Kobayashi, M., Yajima, M., Suyanandana, P., Budka, and Somchai, P. Screening of thermophilic lactic acid bacteria producing bacteriocins in the tropics. 1998:33(2):125-131.

Martirani, L., Varcamonti, M., Naclerio, G., and De Felice, M. Purification and partial characterization of Bacillocin 490, a Novel Bacteriocin produced by athermophilic strains of Bacillus licheniformis. Microbial cell Factories.2002:1(1): 1 – 5.

Ghrairi, T., Chaftar, N., and Hani, K. “Bacteriocins: recent advances and opportunities” in Progress in Food Preservation. Chapter 23. eds R. Bhat, A. Karim Alias and G. Paliyath (Oxford: Wiley-Blackwell). 2012:485–511.

Van Heel, A. J., Montalban-Lopez, M., and Kuipers, O. P. Evaluating the feasibility of lantibiotics as an alternative therapy against bacterial infections in humans. Expert Opin. Drug Metab. Toxicol. 2011:7(6), 675–680. doi: 10.1517/17425255.2011.573478 .

Lancaster, L. E., Wintermeyer, W., and Rodnina, M. V. Colicins and their potential in cancer treatment. Blood Cells Mol. Dis.2007:38(1), 15–18. doi: 10.1016/j.bcmd.2006.10.006

Dobson, A., Cotter, P. D., Ross, R. P., and Hill, C. Bacteriocin production: a probiotic trait? Appl. Environ. Microbiol. 2012:78(1), 1–6. doi: 10.1128/AEM.05576-11

Bernbom,N.,Licht,T.R.,Brogren,C.H.,Jelle,B.,Johansen,A.H.,Badiola,I.,etal. Effects of Lactococcuslactis on composition of intestinal microbiota: role of nisin. Appl.Environ.Microbiol. 2006:72(1):239-244. doi:10.1128/AEM.72.1.239244.2006.

Chumchalová, J., and Smarda, J. Human tumor cells are selectively inhibited by colicins. Folia Microbiol. (Praha). 2003:48(1):111–115. doi: 10.1007/BF029 31286 .

Joo, N. E., Ritchie, K., Kamarajan, P., Miao, D., and Kapila, Y. L. Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med. 2012:1(3):295–305. doi: 10.1002/cam4.35

Rogers, L. A. The inhibiting effect of Streptococcus lactis on Lactobacillus bulgaricus. J. Bacteriol. 1928:16(5)321–325.

Joerger, R. D. Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages. Poult. Sci.2003:82, 640–647]. doi: 10.1093/ps/82.4.640

Cleveland, J., Montville, T. J., Nes, I. F., and Chikindas, M. L. Bacteriocins: safe, natural antimicrobials for food preservation. Int. J. Food Microbiol. 2001:71(1):1–20. doi: 10.1016/S0168-1605(01)00560-8.

Grinter, R., Milner, J., and Walker, D. Bacteriocins active against plant pathogenic bacteria. Biochem. Soc. Trans. 2012:40(6):1498–1502. doi: 10.1042/BST20120206Lancaster, L. E.


Refbacks

  • There are currently no refbacks.